Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

KappAhl half-yearly report: Challenging quarter with bright spots

“…Bright spots in a severely negative market were our lower inventory levels and that growth in eCommerce has continued in line with the strong trend of 30-40-per cent we saw in the past year...”  Read the full CEO statement in the report. · Sales in the quarter decreased by 6.2 per cent to SEK 1,115 (1,189) million and the gross margin decreased by 0.1 percentage points to 58.8 (58.9) per cent. During the first half year sales decreased by 6.9 per cent to SEK 2,280 (2,450) million and the gross margin was 61.8 (62.2) per cent. · Inventory levels continue to be lower; SEK

Hemfosa becomes long-term sole owner of healthcare properties at Gardermoen with green loan financing from Swedbank

Hemfosa has acquired Aspelin Ramm’s ownership stake of 35 percent in Gardermoen Campus Utvikling AS (GCU), a joint venture that has built a specialist hospital and a local medical center in the center of excellence for health services and medical care being established near Gardermoen Airport in Norway. Further development of the area will continue in cooperation with Aspelin Ramm as part of the existing joint venture structure. In connection with the transaction, Hemfosa has secured long-term financing of the hospital and the local medical center with a green loan of SEK 1.5 billion from

NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders

NMD Pharma secures one of the largest Series A financings in Scandinavia from a top tier international syndicate to support development through clinical proof-of-concept of two programs that target orphan neurological disorders and in-hospital critical care indications.Århus, Denmark, March [TBD], 2018 - NMD Pharma A/S, a private biotech company focused on developing novel first in class therapies for severe neuromuscular disorders today announced a transformative €38 million Series A financing led by new investor INKEF Capital, together with new investor Roche Venture Fund and existing

Borr Drilling Limited (BDRILL) – Equity offering successfully completed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO BUY, SELL OR SUBSCRIBE FOR ANY SECURITIES DESCRIBED HEREIN.   Hamilton, Bermuda, 23 March 2018   Reference is made to Borr Drilling Limited's ("Borr Drilling" or the "Company") stock exchange notice dated 22 March 2018 relating to the contemplated equity offering of up to USD 250 million (the “

MTG to split in two and distribute shares in Nordic Entertainment Group to shareholders

The Board of Directors of Modern Times Group MTG AB (publ) (“MTG”) has decided to initiate a process to split MTG into two companies – Modern Times Group MTG AB and Nordic Entertainment Group – by distributing all of the shares in Nordic Entertainment Group (comprising MTG Nordic Entertainment, MTG Studios and Splay Networks) to MTG’s shareholders, and listing these shares on Nasdaq Stockholm. The Board intends to propose the distribution and listing of the shares at an Extraordinary General Meeting (EGM) of its shareholders during the second half of 2018. The Board’s final proposal will be

Höegh LNG : Board approval of 2017 annual financial statements

Bermuda, 23 March 2018 - On 22 March 2018, the board of directors of Höegh LNG Holdings Ltd. (Höegh LNG) approved the 2017 annual financial statements prepared in accordance with International Financial Reporting Standards (IFRS). The statements are in accordance with the preliminary 2017 annual financial statements published on 28 February 2018. The annual report 2017 will be made available on Höegh LNG's web site www.hoeghlng.com in April 2018.  Höegh LNG's annual general meeting will be held on 6 June 2018. * * * About Höegh LNG: Höegh LNG provides floating energy

Restamax Plc: RESTAMAX EXPANDS OPERATIONS TO DENMARK

Restamax PlcSTOCK EXCHANGE RELEASE 23 March 2018, 8:00 amRESTAMAX EXPANDS OPERATIONS TO DENMARKRestamax Plc is expanding its restaurant operations to Denmark. In Denmark, Restamax will operate through its subsidiary Restamax Operations Denmark. The company will buy over 90% of the popular Danish Cock's & Cows and The Bird companies, which currently operate a total of 11 restaurants and bars in Copenhagen.During summer 2018, both restaurant concepts will open new units in prime locations at the Copenhagen international airport. The concept's restaurants are already located in key

Axactor acquires a portfolio of REOs from Cajamar

Madrid, March 22nd, 2018Axactor has acquired a REO portfolio with the appraisal value of more than 26 mEUR from the financial institution Cajamar. The portfolio consists of approximately 650 assets and is the second portfolio acquisition in Spain this year.Axactor continues to develop the investments in the real estate market in Spain through the fifth acquisition in this sector, and with this strengthening the position as a solid and active investor in the Spanish market.With this acquisition from Cajamar, Axactor continues to diversify the company´s product portfolio by growing in

BEWi enters into SPA to acquire Synbra; will assess preconditions for a bond issuance; presents prel. financial information for Jan & Febr 2018

Press release 2018-03-22 at 23:00 On 14 February 2018, BEWi Group AB (publ) (“BEWi”), a leading full-line supplier in the Nordic countries of particle foam products, announced its intention to acquire Synbra Holding B.V. (“Synbra”).Today, BEWi has through a Dutch wholly-owned subsidiary, entered into a share purchase agreement to acquire all the shares in Synbra with certain funds managed by Gilde Buy Out Partners (“Gilde”) and its co-investors as sellers. Completion of the acquisition is subject to financing and regulatory approval. BEWi further announces that it will assess the

Prospectus regarding Starbreeze rights issue is made public

THE INFORMATION IN THIS PRESS RELEASE MAY NOT BE ANNOUNCED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, UNITED STATES, OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, PUBLICATION OR DISTRIBUTION OF THE INFORMATION WOULD NOT COMPLY WITH OR REQUIRE REGISTRATION UNDER APPLICABLE LAWS AND REGULATIONS. STOCKHOLM (22 March, 2018) Prospectus  Prospectus regarding the rights issue in Stabreeze has been approved and registered by Swedish Financial Supervisory Authority and is now

Tieto Corporation: Compositions of the committees of the Board of Directors

Tieto Corporation       STOCK EXCHANGE RELEASE        22 March 2018, 9.30 pm EET Tieto Corporation's Annual General Meeting of Shareholders was held on 22 March 2018. At its constitutive meeting after the AGM, the Board of Directors elected Harri-Pekka Kaukonen as its Deputy Chairman. The Board also appointed a Remuneration Committee comprising ·  Kurt Jofs (Chairman) ·  Johanna Lamminen ·  Endre Rangnes and an Audit and Risk Committee comprising ·  Harri-Pekka Kaukonen (Chairman) ·  Timo Ahopelto ·  Liselotte Hägertz Engstam ·  Jonas Synnergren. All

Press release from the Annual General Meeting of Beijer Alma AB (publ) on March 22, 2018

EXTRACT FROM PRESIDENT HENRIK PERBECK’S STATEMENT AT THE ANNUAL GENERAL MEETING  “Creating the right conditions for the Group companies and their products is now one of my main tasks. It is equally important to continue work with Beijer Alma’s internationalization and to strengthen the excellent platform we have built. And we need to do so by driving growth through carefully selected acquisitions and stronger organic development.”  RESOLUTIONS PASSED AT THE ANNUAL GENERAL MEETING  The following resolutions were passed at the Annual General Meeting:  · The balance sheets and

Annual General Meeting of shareholders in Castellum AB (publ)

At the Annual General Meeting of shareholders in Castellum AB (publ), on Thursday, March 22, 2018, the Board of Directors’ proposal of a distribution of SEK 5.30 per share, distributed to the shareholders in two equal payments of SEK 2.65 per share, was confirmed. The first record day for distribution was decided to be Monday, March 26, 2018 and the second record day for distribution was decided to be Monday, September 24, 2018. Further the AGM decided to re-elect the existing Board members Charlotte Strömberg, Per Berggren, Anna-Karin Hatt, Christer Jacobson, Christina Karlsson Kazeem,

Scientific journal highlights study of the DRP tool in cisplatin treatment for patients with lung cancer

Hoersholm, Denmark – March 22,  2018 – Oncology Venture Sweden AB:s (OV:ST) (“Oncology Venture” or “OV”) and Medical Prognosis Institute (MPI.ST) (“Medical Prognosis Institute” or “MPI”) announces positive study results for the diagnostic tool DRP® in lung cancer patients treated with cisplatin. The findings have been published in the scientific journal  PLOS ONE under the title “Molecular Prediction of adjuvant cisplatin efficacy in Non-small cell lung cancer – validation in two independent cohorts.”  Data from both a prospective randomized clinical trial and a Danish NSCLC patient cohort

Decisions of Raute Corporation’s Annual General Meeting 2018

RAUTE CORPORATION STOCK EXCHANGE RELEASE 22 MARCH 2018 at 7:55 p.m.  DECISIONS OF RAUTE CORPORATION’S ANNUAL GENERAL MEETING 2018Raute Corporation’s Annual General Meeting on 22 March 2018 confirmed the Financial Statements for 1 January to 31 December 2017 and discharged the members of the Board of Directors and President and CEO from liability.The Annual General Meeting decided according to the proposal of the Board of Directors to distribute a dividend of EUR 1.25 per a series A and K share, with the payment date 4 April 2018. The record date is 26 March 2018.The Annual General

Annual General Meeting of shareholders in Hufvudstaden 2018

Hufvudstaden held its Annual General Meeting today at the Grand Hôtel, Vinterträdgården, in Stockholm. The Meeting adopted the Board of Directors’ proposal of a dividend of SEK 3.50 per share. The record date is Monday March 26, 2018 and the estimated date ofdividend payment is Thursday March 29, 2018. Fredrik Lundberg, Claes Boustedt, Peter Egardt, Liv Forhaug, Louise Lindh, Fredrik Persson Sten Peterson, Anna-Greta Sjöberg and Ivo Stopner were re-elected to the Board of Directors. Fredrik Lundberg was re-elected Chairman of the Board. The Meeting decided that remuneration of

Wihlborgs develops Gängtappen together with Media Evolution

Wihlborgs has signed a lease with Media Evolution, which will move into two storeys, a total of 1,600 m², of Gängtappen in Malmö, Sweden.Media Evolution aims to boost growth and innovation in digital industries and is owned by its members, at present 400 companies and organisations. Together with Wihlborgs, it created Media Evolution City at Dockan in Malmö in 2012. Now, Wihlborgs and Media Evolution are taking the next joint step in this venture in Gängtappen, which was once the head office of Kockums, and is only a stone’s throw from Media Evolution City. “Media Evolution has meant

Cherry updates financial information on acquisition of Game Lounge

Cherry AB (publ) – STO: CHER-B.ST – announced 22 December 2017 that the company is acquiring the majority of shares outstanding in the leading affiliate company Game Lounge Ltd. The acquisition is intended to be paid through a combination of equal portions cash and newly issued shares in Cherry AB (publ). Cherry can now announce that the purchase consideration has been determined to approximately SEK 189.2 million, of which the cash portion is expected to amount to approximately SEK 94.6 million.The purchase consideration for an additional 44 percent of the shares in Game Lounge Ltd that is

Lokelma approved in the EU

22 March 2018 16:45 GMT Lokelma approved in the EU for the treatment of adults with hyperkalaemia Patients will benefit from Lokelma's rapid reduction and sustained control of potassium levels in the blood4,5 AstraZeneca today announced that the European Commission has granted marketing authorisation for Lokelma (formerly ZS-9, sodium zirconium cyclosilicate) for the treatment of adults with hyperkalaemia. Hyperkalaemia is a serious condition characterised by elevated potassium levels in the blood associated with cardiovascular, renal and metabolic diseases.1,2,3,4 Lokelma is a

Approval of annual accounts 2017

The board of directors of NextGenTel Holding ASA has 22 March 2018 approved the annual accounts for 2017. There were only minor changes in the profit for the year as presented in the Q4 2017 financial report, primarily related to income tax expense. The annual general meeting (AGM) will take place Tuesday 24 April 2017 at 15:00 at the company's premises at Harbitzalleen 2A, Skøyen, Oslo. A notice for the AGM will be sent to all shareholders and documents related to the AGM, including the annual report for 2017, will be available on the company's investor relations website (www.

Welcome to Annual General Meeting 2018

Shareholders of ÅF AB (publ) are invited to the annual general meeting to be held on Wednesday, 25 April 2018 at 4 pm (CET) at the company headquarters on Frösundaleden 2A, Stockholm, Sweden. Registration starts at 3:30 pm (CET).Registration and participation Shareholders who wish to participate in the Annual General Meeting shall ·  be included in the shareholders’ register maintained by Euroclear Sweden AB on Thursday, 19 April 2018, and ·  give notice of attendance no later than Thursday, 19 April 2018 via ÅF’s website www.afconsult.com 

Tieto Corporation: Decisions of the Annual General Meeting on 22 March 2018

Tieto Corporation        STOCK EXCHANGE RELEASE        22 March 2018, 6.00 pm EET Tieto Corporation's Annual General Meeting of Shareholders approved the financial statements for 2017, decided to distribute a dividend of EUR 1.20 per share and additional dividend of EUR 0.20 as well as to discharge the company's officers from liability for the financial year 2017. The dividend settlement date is 26 March 2018 and the dividend will be paid as from 9 April 2018. In addition, the Annual General Meeting made the following decisions: Board composition and remuneration The meeting

Camurus Annual Report for 2017

Lund — 22 March 2018 — Camurus (CAMX) today announces that the Annual Report for 2017 now is available at the company’s website: www.camurus.com. About CamurusCamurus is a Swedish research-based pharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the proprietary FluidCrystal® drug delivery technologies and an extensive R&D expertise. Camurus’ clinical pipeline includes products for treatment of cancer, endocrine

There are no items matching the current filter
There are no more items matching the current filter
Back to top